
France is one of the top five sources of foreign direct investment in the United States, with dozens of CAC 40 companies operating major American subsidiaries: LVMH, Sanofi, TotalEnergies, Schneider Electric, L’Oréal, Saint-Gobain, Dassault Systèmes, Capgemini, Sodexo, Air Liquide, and many more. The 2025 Choose France summit announced a record €40.8 billion in foreign investment projects. French pharmaceutical companies, luxury houses, aerospace manufacturers, technology firms, and industrial groups have been building American operations for decades. The capital commitment is serious and sustained.
We know this market better than most. Pact & Partners is a boutique executive search firm — founded in 1987 — that helps foreign companies of all sectors recruit executive talent for their US operations. Our CEO, Olivier Safir, is French-American with a JD/MBA, and has spent 20+ years placing executives across borders. Headquartered in Miami with a Boston office, we serve clients from 30+ countries.
For the broader European perspective, see our European companies guide. For a detailed look at the French–U.S. executive search corridor, see our France to USA country page.
In France, the Président-Directeur Général (PDG) traditionally combines the roles of chairman and CEO, concentrating strategic and operational authority in one person. Even in companies that have separated the two roles, French corporate governance tends toward centralized decision-making at the top, with information flowing up and directives flowing down. Hofstede’s cultural dimensions research scores France at 68 on power distance — significantly higher than the U.S. at 40.
The Cost of a Failed Executive Hire
Sources: SHRM, Harvard Business Review, Heidrick & Struggles (2024–2025 data)
What this means for U.S. executive hiring: American executives expect to participate in strategic discussions, make operational decisions independently, and push back on directives they believe are wrong. A French headquarters that treats the U.S. subsidiary leader as an executor of Parisian decisions — rather than an autonomous business leader — will frustrate and eventually lose every strong American hire. The mismatch is not about competence. It is about authority. French companies that succeed in U.S. hiring define which decisions the American leader makes independently and which require headquarters consultation — and they commit to those boundaries in writing before the search begins.
Practitioner insight: We frequently see French companies define the U.S. role as “Directeur Général de la filiale américaine” — General Manager of the American subsidiary. But in practice, the DG cannot sign contracts above €50,000 without Paris approval, cannot hire anyone without the DRH’s sign-off, and cannot change the pricing model without the Directeur Commercial’s agreement. This is not a general manager role by American standards. It is a site manager. If you call it a GM, you must give it GM authority.
French education — from lycée through the Grandes Écoles — trains students in intellectual rigor, structured argumentation, and the thesis-antithesis-synthesis model. This produces executives who are brilliant analytical thinkers, skilled debaters, and deeply thorough in their preparation. It also produces a meeting culture where multiple sessions may occur without a decision being made. The meeting is a forum for intellectual exploration, not an action checkpoint.
American meeting culture is the opposite. Meetings exist to make decisions, assign action items, and create accountability. An American VP of Sales who attends three consecutive meetings in which the French headquarters team debates options without resolving anything will conclude that the company is paralyzed. The frustration is real and it is the second most common reason American executives leave French-owned companies (after the authority issue described above).
The fix is not to stop debating. French analytical rigor is a genuine competitive advantage. The fix is to separate the debate phase from the decision phase, and to make the American executive aware that the debate is productive, not directionless. Set a decision deadline before the first meeting. Debate thoroughly. Decide on schedule. American executives will respect the process if they trust that it leads to action.
In France, educational pedigree shapes career trajectories to a degree that Americans find hard to comprehend. Graduates of École Polytechnique, HEC Paris, Sciences Po, ENA, and the other Grandes Écoles are automatically placed on the “cadre” management track. Career progression, network access, and executive selection are heavily influenced by where you studied, not just what you have achieved.
This credentialism does not transfer to the American market. A U.S. VP of Sales who attended a state university, built three successful sales organizations, and generated $200M in cumulative revenue is a stronger candidate than an HEC graduate who has spent 15 years in French headquarters roles with no U.S. market experience. French companies that filter American candidates through a Grandes Écoles lens — penalizing those without elite academic credentials — systematically screen out the most qualified American executives.
Conversely, French companies should not assume that American candidates understand or value French academic prestige. When presenting the company to candidates, lead with business results, market position, and the U.S. growth plan — not with the PDG’s École Polytechnique credentials.
French executive compensation includes base salary, variable bonus (prime variable, often 10–25% of base for most non-CAC 40 roles), employer social contributions (cotisations patronales, roughly 40–45% of gross salary), complementary retirement (retraite complémentaire), and mutual health insurance (mutuelle). Equity compensation is rare outside of CAC 40 and tech companies. Total cost to the company is high, but the executive’s take-home pay is modest by American standards due to the heavy social charge burden.
American executive compensation operates on entirely different architecture: base salary (40–60% of total comp), annual performance bonus (30–100% of base, with explicit KPI targets), long-term equity incentives (stock options, RSUs, or phantom equity), and benefits (employer-sponsored health insurance, 401(k) matching, PTO). No social charges. No mandatory mutual. No complementary retirement.
The critical conversion problem: A French DG earning €180,000 gross base salary plus €30,000 variable in Paris costs the company approximately €300,000 fully loaded with social charges. But the executive’s net take-home is roughly €130,000–€140,000. An equivalent U.S. role pays $300,000–$500,000 in total compensation, with $200,000–$300,000 in take-home. French companies that benchmark U.S. offers against the French gross salary underquote by 25–45%. Companies that benchmark against French net salary are horrified by U.S. expectations. Neither benchmark is valid. You must use U.S. market data.
Indicative C-Suite Compensation — French Subsidiary / Mid-Market (U.S.)
Role | Base Salary (USD) | Total Comp (USD) | Source / Notes |
|---|---|---|---|
CEO / DG | $250K–$500K | $400K–$1.2M | Varies by revenue; includes bonus + equity |
CFO / DAF | $200K–$400K | $300K–$800K | 34–39% of CEO comp (Page Executive 2025) |
CTO / DSI | $200K–$380K | $300K–$800K | Premium in tech hubs (SF, NYC, Boston) |
VP Sales / DC | $160K–$280K | $250K–$550K | OTE heavily commission-weighted |
VP Regulatory | $180K–$320K | $280K–$600K | Premium in pharma/biotech (Boston, NJ) |
COO / DG Adj. | $200K–$375K | $300K–$750K | Variable by operational scope |
French companies — especially family-owned ETI (Entreprises de Taille Intermédiaire) and non-listed PME — are culturally resistant to equity grants. Equity is seen as family patrimony, not a recruitment tool. This is a structural disadvantage. American executives expect equity. If you cannot grant real equity, create a phantom equity or long-term cash incentive plan that replicates the alignment. For CFO-level benchmarks, see our CFO Complete Guide for 2026.
The French Code du Travail is one of the most protective employment law frameworks in the world. CDI (Contrat à Durée Indéterminée) employees enjoy extensive termination protections, mandatory notice periods, severance indemnities calculated by tenure, works council (CSE) consultation requirements for collective decisions, and 5+ weeks of paid leave. French HR teams are trained to operate within this framework.
None of it applies in the United States. The U.S. at-will system has no mandatory notice, no statutory severance, no works council, and no unfair dismissal tribunal. French DRH (Directeur des Ressources Humaines) teams who try to replicate French employment practices in the U.S. create documents that confuse American candidates, signal unfamiliarity with the market, and sometimes inadvertently create contractual obligations that are more restrictive than U.S. law requires.
The most common errors: offering three-month notice periods (American standard is two weeks or none), building elaborate termination procedures into the offer letter (at-will means at-will), including non-compete clauses modeled on French clauses de non-concurrence (U.S. enforceability varies dramatically by state — California bans them almost entirely). Have a U.S. employment attorney draft the offer letter. Do not translate the French CDI template.
Pact & Partners is a boutique executive search firm — founded in 1987 — that helps foreign companies of all sectors recruit executive talent for their US operations. Under the leadership of CEO Olivier Safir — who is French-American with a JD/MBA — we have spent since 1987 in executive search, with US placements since 2006 placing executives for foreign companies across 30+ countries.MiamiMiamiMiamiMiami
This is not generic cross-border expertise. We understand the PDG dynamic from the inside. We know why the DRH and the Directeur Commercial need to be aligned before the search begins. We speak French with headquarters and American English with candidates. We know that the French company’s first U.S. hire is usually a Directeur Général de filiale, that the real challenge is getting Paris to let them operate, and that the compensation conversion from French social-charge-loaded packages to American equity-heavy packages is where most searches stall.
Meet the team or book a meeting with our CEO to discuss your U.S. search.
1. Centralizing all decision authority in Paris. If the U.S. DG cannot approve a $50K expense without Parisian sign-off, the role has a title but no authority. Define boundaries before the search.
2. Filtering American candidates through Grandes Écoles criteria. A state university graduate with $200M in U.S. revenue generation is a stronger hire than an HEC alumnus with no American market experience.
3. Underquoting compensation by 25–45%. French gross salary benchmarks do not translate. Use U.S. market data.
4. Offering no equity. Family-owned ETI and PME companies that refuse equity participation lose to American employers who include it as standard. Create a phantom equity or long-term incentive mechanism.
5. Running a debate-without-deadline hiring process. Intellectual rigor is an asset. A four-month decision timeline is a liability. Set a decision deadline before the first interview and honor it.
6. Translating the CDI template instead of using a U.S. offer letter. Three-month notice periods, French-style non-competes, and elaborate termination procedures confuse American candidates. Use a U.S.-drafted at-will letter.
7. Sending five headquarters executives to interview one candidate. The DG, DRH, DAF, Directeur Commercial, and a board member all fly to New York for a panel interview. The candidate reads this as bureaucratic and headquarters-controlled. Two to three interviewers per stage.
8. Underestimating U.S. regional differences. A French pharma company belongs in Boston. A French tech company may belong in San Francisco or New York. A French food company may belong in the Midwest or Southeast. The U.S. is 50 markets, not one. See our Best State Checklist.
France’s pharmaceutical industry — Sanofi, Servier, Ipsen, Biomérieux, and dozens of biotech startups — has deep roots in the U.S. market, particularly in the Boston and New Jersey life sciences corridors. The most common hires are Chief Medical Officers, VP Regulatory Affairs, VP Clinical Operations, and Commercial Directors. This was P&P’s founding specialization, and the corridor we know most intimately.
LVMH, Hermès, Kering, L’Oréal, and Chanel operate massive U.S. businesses. Executive hiring in luxury focuses on commercial leadership (Retail Directors, VP of Wholesale, Chief Marketing Officers) and requires candidates who understand both American consumer culture and the brand discipline of French luxury houses.
Dassault Systèmes, Capgemini, Atos, OVHcloud, and a growing French tech market (La French Tech) are expanding U.S. operations. The hiring challenge: French tech companies often build products in France and sell in the U.S., requiring American commercial leaders who can translate French engineering excellence into American market traction.
Schneider Electric, Saint-Gobain, Air Liquide, TotalEnergies, and Michelin have been operating in the U.S. for decades. Newer entrants include mid-market manufacturers and energy transition companies. Executive needs center on operational leadership, supply chain management, and U.S. regulatory compliance.
A mid-market French pharmaceutical company expanding clinical operations to Boston had lost two U.S. hires in 18 months — both resigned citing “inability to make decisions without Paris approval.” Before the third search, the PDG and the search firm drafted a written decision-authority matrix: the U.S. VP of Clinical Operations could approve budgets up to $200K, hire team members up to director level, and engage CROs independently. Decisions above those thresholds required PDG consultation within 48 hours. The matrix was shared with candidates during the interview process. The third hire stayed four years and led the company’s first FDA approval.
A family-owned French industrial company (ETI, €500M revenue) hiring a U.S. CEO initially refused equity participation. The founder’s position: “This is a family company. We do not share equity.” After losing two top candidates who cited the lack of equity as a deal-breaker, the company’s legal counsel created a phantom equity plan tied to U.S. subsidiary EBITDA growth. The phantom plan gave the U.S. CEO an economic stake without diluting family ownership. The eventual hire generated $45M in U.S. revenue within three years. The founder later extended the phantom equity model to the global leadership team.
A French SaaS company’s U.S. CRO told the search firm during a retention check-in: “Every strategic decision goes through three rounds of debate in Paris before anything happens. By the time we agree to pursue an opportunity, the American competitor has already closed the deal.” The company implemented a “decision by date” protocol: every strategic discussion had a defined resolution date. Debates continued — the French analytical rigor remained — but decisions now had deadlines. U.S. deal velocity improved by 40% within two quarters.